Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betaine in Children With Peroxisome Biogenesis Disorders
NCT01838941Phase 3Completed
- Sponsor
- McGill University Health Centre
- Start
- Mar 2013
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of betaine in Peroxisome biogenesis disorders (PBDs), sponsored by McGill University Health Centre. Started Mar 2013; status: completed.
02
Drugs
betaine
03
Conditions
Peroxisome biogenesis disorders (PBDs)
Beyond the preview
Go deeper on NCT01838941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01838941.